TrialInternational journal of radiation oncology, biology, physics2014

Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer.

Nestor F Esnaola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.